Nuvora, Inc., Creators of Salese, Helps Spread Awareness of the Importance of Good Oral Care for Diabetics
(PRWEB) November 14, 2013 -- November is American Diabetes Month and a time to increase awareness of this disease that is reaching epidemic proportions. Approximately 25.8 million adults and children in the U.S. suffer from diabetes, a condition that can cause numerous complications including nerve damage, kidney damage, vision problems as well as oral health issues, such as gingivitis, periodontitis and dry mouth(1). Proper education to help prevent diabetes as well as help those who have been diagnosed to stay healthy is essential.
For people with diabetes, dry mouth can result as a symptom of high blood glucose or as side effect of prescription and over the counter medications(2). Symptoms of dry mouth include thirst, bad breath, trouble chewing or swallowing, cracked lips or a dry tongue. If left untreated, dry mouth can lead to other serious oral hygiene problems including tooth decay, cavities, gum disease and salivary gland infections. Just as high blood glucose levels can cause dry mouth, oral infections caused by dry mouth can also cause blood glucose levels to increase(3).
“Proper oral hygiene is important for anyone who suffers from dry mouth but this is especially true for people with diabetes,” explains Bolko Stolberg, Executive Vice President of Nuvora Inc., creator of Salese. “Salese Soft Lozenges offer long lasting relief and comfort of dry mouth while also helping to improve the overall health of your mouth, leaving you with fresh breath and a clean feel.”
For optimal oral hygiene, diabetics should drink plenty of water, maintain blood glucose levels with a healthy diet and regular exercise, floss and brush teeth twice a day and have regular dental check-ups. For people with dry mouth, dentists may recommend artificial saliva or specialized mouth washes to help keep the mouth moisturized. Salese is a sugar free and alcohol free soft lozenge that provides hours of dry mouth relief utilizing Nuvora’s patented SuRe™ (Sustained Release) drug delivery technology. Conventional dry mouth products like toothpaste, mouth wash, chewing gums and mints may be washed away in minutes, while Salese Soft Lozenges slowly dissolves while offering continuous relief over a prolonged period of time. In addition to relieving dry mouth, Salese also kills up to 99.9% of bacteria in the mouth, neutralizing acidic pH and eliminate germs that cause bad breath. Salese is available for $5.99 in Peppermint and Wintergreen and in a sensitive formulation for people with mouth sensitivity at ShopRite, DrugStore.com and Walgreens.com.
To learn more about Salese, please visit http://nuvorainc.com/products/salese. To coordinate an interview with Bolko Stolberg, Executive Vice President of Nuvora Inc., or to request samples of Salese, please contact Lauren Verini, lauren(at)adinny(dot)com, 212.693.2150 x311.
About Nuvora, Inc.
Nuvora, Inc. is a Santa Clara, California company focused on developing innovative oral care products. The company was started by experienced drug delivery experts with a proven track record in taking a variety of ground breaking delivery technologies from concept through clinical trials to market. Nuvora’s proprietary Sustained Release technology (SuRe™) is used to form an extended release ‘lozenge’. This lozenge which can last anywhere from 30 minutes to over 2 hours, acts upon the oral cavity with substantially lower therapeutic doses of active ingredients for a substantially longer duration. As a result, the SuRe technology may achieve unprecedented prolonged activity and efficacy for ingredients delivered in the oral cavity. Nuvora, Inc. currently manufactures and markets Salese™ for Dry Mouth (Xerostomia) and Dentiva™ for general oral hygiene.
(1) National Institute of Dental and Craniofacial Research, http://www.nidcr.nih.gov/OralHealth/Topics/Diabetes/
(2) Joslin Diabetes Center, http://www.joslin.org/info/high_blood_glucose_what_it_means_and_how_to_treat_it.html
(3) American Dental Association, July 2010, http://www.ada.org/sections/scienceAndResearch/pdfs/FortheDentalPatient_July_2010.pdf
Lauren Verini, ADinfinitum, +1 2126932150 Ext: 311, [email protected]
Share this article